Meglumine lodipamide (Cholografin®) Hepatotoxicity
- L. R. SUTHERLAND, M.D.;
- L. A. EDWARDS, M.D., F.R.C.P.(C);
- A. MEDLINE, M.D., F.R.C.P.(C);
- R. W. WILKINSON, M.D., F.R.C.S.(C); and
- J. J. CONNON, M.D., M.R.C.P.(Lond), F.R.C.P.(C)
Abstract
Two cases of meglumine iodipamide (Cholografin®) hepatotoxicity were confirmed by liver biopsy. The hepatic lesion was centrilobular in location and resolved within a short period of time. Nausea and vomiting commonly reported after intravenous cholangiography may be clinical manifestations of this entity.
Article and Author Information
-
▸From the Departments of Medicine, Pathology, and Surgery, Toronto Western Hospital; and the Department of Medicine, Humber Memorial Hospital; Toronto, Canada.
-
▸Requests for reprints should be addressed to J. J. Connon, M.D.; Department of Medicine (Gastroenterology), Toronto Western Hospital, 399 Bathurst St.; Toronto, ON M5T 2S8, Canada.
-
- Received July 21, 1976.
- Accepted January 12, 1977.
Related Clinical Content
Most Read
